申请人:Fujisawa Pharmaceutical Co., Ltd.
公开号:US04994453A1
公开(公告)日:1991-02-19
The disclosure deals with pyrazolopyridine compounds of the formula ##STR1## wherein the variables are defined in the specification. The compounds are useful in the treatment of bronchial asthma, immunosuppression, diabetes, etc.
该披露涉及公式为##STR1##的吡唑吡啶化合物,其中变量在规范中定义。这些化合物在治疗支气管哮喘、免疫抑制、糖尿病等方面是有用的。